Dynavax Technologies (DVAX) Income from Continuing Operations: 2009-2024
Historic Income from Continuing Operations for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to $27.3 million.
- Dynavax Technologies' Income from Continuing Operations rose 53.05% to $26.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$43.4 million, marking a year-over-year decrease of 311.57%. This contributed to the annual value of $27.3 million for FY2024, which is 527.44% up from last year.
- Latest data reveals that Dynavax Technologies reported Income from Continuing Operations of $27.3 million as of FY2024, which was up 527.44% from -$6.4 million recorded in FY2023.
- In the past 5 years, Dynavax Technologies' Income from Continuing Operations registered a high of $293.2 million during FY2022, and its lowest value of -$75.2 million during FY2020.
- For the 3-year period, Dynavax Technologies' Income from Continuing Operations averaged around $104.7 million, with its median value being $27.3 million (2024).
- Its Income from Continuing Operations has fluctuated over the past 5 years, first slumped by 102.18% in 2023, then skyrocketed by 527.44% in 2024.
- Dynavax Technologies' Income from Continuing Operations (Yearly) stood at -$75.2 million in 2020, then surged by 201.96% to $76.7 million in 2021, then soared by 282.15% to $293.2 million in 2022, then tumbled by 102.18% to -$6.4 million in 2023, then surged by 527.44% to $27.3 million in 2024.